About Vandria
We are developing first-in-class small molecules against a novel target to improve mitochondrial function and reduce chronic inflammation to treat age-related diseases.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Epalinges, Switzerland
Team Size
1–10 employees
Tracked Since
Nov 8, 2026
Web & Domain Identity
Official Website
vandria.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $30,700,000 · Series-A
Backed by +ND Capital
- Capital Raise
Raised $20,600,000 · Series-A
Backed by +ND Capital
Investors & Backers
+ND Capital
Lead
Dolby Family Ventures
Eurostars
Hevolution Foundation
Innosuisse
Funding History
Series-A equity
· Aug 21, 2024
Round backers: +ND Capital
$30,700,000 fundraisingfox.com
Series-A equity
· Dec 14, 2023
Round backers: +ND Capital
$20,600,000 startupticker.ch
Founders & Leadership
Peter Harboe-Schmidt
Head of Finance
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026